Kaoru Mitsui

Kaoru Mitsui

Auto-generated profile, based on publicly available information

Kaoru Mitsui

Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Gene Therapy & Regenerat Med, Kagoshima 8908544, Japan

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2003 in Cell
Verified
Journal Article
Closed access
KMKaoru Mitsui
Kaoru Mitsui
YTYoshimi Tokuzawa
Yoshimi Tokuzawa
HIHiroaki Itoh
Hiroaki Itoh
KSKohichi Segawa
Kohichi Segawa
MMMirei Murakami
Mirei Murakami
SYShinya Yamanaka
Shinya Yamanaka

26 June 1997 in Nature
Verified
Journal Article
Closed access
PDF file
TETakaho A. Endo
Takaho A. Endo
MMMasaaki Masuhara
Masaaki Masuhara
MYMasahiro Yokouchi
Masahiro Yokouchi
RSRitsu Suzuki
Ritsu Suzuki
HSHiroshi Sakamoto
Hiroshi Sakamoto
AYAkihiko Yoshimura
Akihiko Yoshimura

29 May 2003 in Nature
Verified
Journal Article
Open access
PDF file
KTKazutoshi Takahashi
Kazutoshi Takahashi
KMKaoru Mitsui
Kaoru Mitsui
SYShinya Yamanaka
Shinya Yamanaka
Embryonic stem (ES) cells are pluripotent cells derived from early mammalian embryos1,2. Their immortality and rapid growth make them attractive sources for stem cell therapies3; however, they produce tumours (teratomas) when transplanted, which could preclude their therapeutic usage4. Why ES cells, which lack chromosomal abnormalities, possess tumour-like properties is largely unknown. Here we show that mouse ES cells specifically express a Ras-like gene, which we have named ERas. We show that human HRasp, which is a recognized pseudogene, does not contain reported base substitutions and instead encodes the human orthologue of ERas. This protein contains amino-acid residues identical to those present in active mutants of Ras5 and causes oncogenic transformation in NIH 3T3 cells. ERas interacts with phosphatidylinositol-3-OH kinase6 but not with Raf7,8. ERas-null ES cells maintain pluripotency but show significantly reduced growth and tumorigenicity, which are rescued by expression of ERas complementary DNA or by activated phosphatidylinositol-3-OH kinase. We conclude that the transforming oncogene ERas is important in the tumour-like growth properties of ES cells.

19 March 1999 in FEBS Letters
Verified
Journal Article
Closed access
STShyu Tanimura
Shyu Tanimura
SOSatoshi Ohtsuka
Satoshi Ohtsuka
KMKaoru Mitsui
Kaoru Mitsui
KSKazuo Shirouzu
Kazuo Shirouzu
AYAkihiko Yoshimura
Akihiko Yoshimura
MOMotoaki Ohtsubo
Motoaki Ohtsubo

1 April 2003 in Molecular and Cellular Biology
Verified
Journal Article
Open access
PDF file
YTYoshimi Tokuzawa
Yoshimi Tokuzawa
EKEiko Kaiho
Eiko Kaiho
MMMasayoshi Maruyama
Masayoshi Maruyama
KTKazutoshi Takahashi
Kazutoshi Takahashi
KMKaoru Mitsui
Kaoru Mitsui
SYShinya Yamanaka
Shinya Yamanaka
Embryonic stem (ES) cells are immortal and pluripotent cells derived from early mammalian embryos. Transcription factor Oct3/4 is essential for self-renewal of ES cells and early mouse development. However, only a few Oct3/4 target genes have been identified. In this study, we found that F-box-containing protein Fbx15 was expressed predominantly in mouse undifferentiated ES cells. Inactivation of Oct3/4 in ES cells led to rapid extinction of Fbx15 expression. Reporter gene analyses demonstrated that this ES cell-specific expression required an 18-bp enhancer element located approximately 500 nucleotides upstream from the transcription initiation site. The enhancer contained an octamer-like motif and an adjacent Sox-binding motif. Deletion or point mutation of either motif abolished the enhancer activity. The 18-bp fragment became active in NIH 3T3 cells when Oct3/4 and Sox2 were coexpressed. A gel mobility shift assay demonstrated cooperative binding of Oct3/4 and Sox2 to the enhancer sequence. In mice having a β-galactosidase gene knocked into the Fbx15 locus, 5-bromo-4-chloro-3-indolyl-β-d-galactopyranoside staining was detected in ES cells, early embryos (two-cell to blastocyst stages), and testis tissue. Despite such specific expression of Fbx15, homozygous mutant mice showed no gross developmental defects and were fertile. Fbx15-null ES cells were normal in morphology, proliferation, and differentiation. These data demonstrate that Fbx15 is a novel target of Oct3/4 but is dispensable for ES cell self-renewal, development, and fertility.

1 October 1997 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
MMMasaaki Masuhara
Masaaki Masuhara
HSHiroshi Sakamoto
Hiroshi Sakamoto
AMAkira Matsumoto
Akira Matsumoto
RSRitsu Suzuki
Ritsu Suzuki
HYHideo Yasukawa
Hideo Yasukawa
AYAkihiko Yoshimura
Akihiko Yoshimura